MoonLake Immunotherapeutics (MLTX): One of Oppenheimer's Top Stock Picks For the Next 12 Months
Oppenheimer's top stock picks for the next 12 months include MoonLake Immunotherapeutics (NASDAQ: MLTX), ranking 5th. MLTX, a biotech company, is developing a treatment for various ailments. Although promising, AI stocks may offer greater returns in a shorter timeframe.